What is Niacin (Vitamin B3) used for?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Uses of Niacin (Vitamin B3)

Niacin is primarily used as a lipid-modifying agent to treat various forms of dyslipidemia, but its routine use has declined due to limited cardiovascular outcome benefits and significant side effects.

Primary Clinical Uses

Lipid Management

  • Reduces LDL cholesterol by up to 25%
  • Lowers triglycerides by up to 50%
  • Increases HDL cholesterol by up to 30% (most effective agent available for raising HDL)
  • Reduces lipoprotein(a) by up to 30% 1

Specific Indications

  1. Primary hyperlipidemia and mixed dyslipidemia - as adjunct to diet when non-pharmacologic measures are inadequate 2
  2. Secondary prevention - to reduce risk of recurrent myocardial infarction in patients with history of MI and hyperlipidemia 2
  3. Atherosclerotic disease progression - in combination with bile acid binding resins to slow progression or promote regression of atherosclerotic disease 2
  4. Severe hypertriglyceridemia - as adjunctive therapy for patients at risk of pancreatitis who don't respond adequately to dietary measures 2

Dosing Considerations

  • Starting dose: 500 mg at bedtime to reduce side effects
  • Maintenance dose: 1000-2000 mg daily (titrated gradually)
  • Administration: Should be taken at bedtime after a low-fat snack 2
  • Formulations:
    • Immediate-release (IR)
    • Sustained-release (SR)
    • Extended-release (ER) - preferred due to better side effect profile 3

Monitoring Requirements

According to ACC/AHA guidelines, the following should be monitored 4:

  • Baseline hepatic transaminases, fasting blood glucose or HbA1c, and uric acid
  • Repeat during dose titration and every 6 months thereafter

Safety Concerns and Limitations

Major Side Effects

  • Flushing and pruritus - most common side effect, can be mitigated by taking aspirin 325 mg 30 minutes before dosing 4
  • Hepatotoxicity - risk increases with sustained-release formulations 3
  • Hyperglycemia - can worsen glycemic control in diabetic patients 4
  • Hyperuricemia - can precipitate gout 4
  • Gastrointestinal symptoms - abdominal pain, nausea 4

Contraindications

Niacin should not be used in patients with 4:

  • Hepatic transaminase elevations >2-3 times upper limit of normal
  • Persistent severe cutaneous symptoms
  • Persistent hyperglycemia
  • Acute gout
  • Unexplained abdominal pain or GI symptoms
  • New-onset atrial fibrillation or weight loss

Current Role in Therapy

The role of niacin has diminished in recent years due to:

  1. Limited cardiovascular outcome benefits - The AIM-HIGH and HPS2-THRIVE trials showed no reduction in cardiovascular events when niacin was added to statin therapy 1

  2. Significant side effect profile - Limiting patient adherence and clinical utility 1

  3. Availability of better-tolerated alternatives - Statins have become first-line therapy for most dyslipidemias 4

Specialized Uses

Niacin may still be considered in specific scenarios:

  • Statin intolerance - As an alternative when statins cannot be used 1
  • Severe familial hypercholesterolemia - As part of combination therapy 1
  • Very high Lp(a) levels - As one of few agents that can lower this parameter 1

Historical Context

Niacin has a long history in cardiovascular disease management. The Coronary Drug Project demonstrated that niacin monotherapy reduced recurrent myocardial infarction and long-term mortality in hypercholesterolemic men 1, 5. However, more recent evidence has led to a reevaluation of its role in contemporary practice.

References

Guideline

Niacin Therapy for High Cholesterol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Understanding niacin formulations.

The American journal of managed care, 2002

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.